Title : The Influence of the CES1 Genotype on the Pharmacokinetics of Enalapril in Patients with Arterial Hypertension.

Pub. Date : 2022 Apr 5

PMID : 35455696






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The angiotensin-converting enzyme inhibitor enalapril is hydrolysed to an active metabolite, enalaprilat, in the liver via carboxylesterase 1 (CES1). Enalaprilat carboxylesterase 1 Homo sapiens
2 The angiotensin-converting enzyme inhibitor enalapril is hydrolysed to an active metabolite, enalaprilat, in the liver via carboxylesterase 1 (CES1). Enalaprilat carboxylesterase 1 Homo sapiens
3 Mean peak and trough enalaprilat concentrations, adjusted by clinical variables, were significantly lower in CES1 rs2244613 heterozygotes (by 16.6% and 19.6%) and in CC homozygotes (by 32.7% and 41.4%) vs. the AA genotype. Enalaprilat carboxylesterase 1 Homo sapiens